Dpco

(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India
Ministry of Chemicals and Fertilizers
Department of Pharmaceuticals
National Pharmaceutical Pricing Authority
New Delhi, the 19th December, 2022
ORDER
S. O. 5938(E):- In exercise of the powers conferred by paragraphs 4, 6, 10, 11, 14, 16, 17 and 18 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated 30th May, 2013 and S.O. 5249(E) dated 11th November, 2022 issued by the Government of India the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No SO 1499(E) dated 30th March, 2022 and SO No 4589(E) dated 29th September, 2022 in so far as it relates to formulation packs mentioned in the table below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as specified in column (5) of the table herein below as ceiling price exclusive of goods and services tax applicable, if any, in respect of the Scheduled formulation specified in the corresponding entry in column (2) of the said Table with the dosage form & strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof:
TABLE
Sl. No.
(1)
1
2
3
4
5
6
7
8
9
10
11
(2)
Name of the Scheduled Formulation
Paracetamol
Allopurinol
Hydroxychloroquine
Carbamazepine
Carbamazepine
Carbamazepine
Clobazam
Clobazam
Levetiracetam
Levetiracetam
Levetiracetam
(3)
Dosage form and strength
Tablet 650mg
Tablet 300mg
Tablet 400mg
Modified Release – Tablet 200mg
Modified Release – Tablet 400mg
Tablet 400mg
Tablet 5mg
Tablet 10mg
Tablet 250mg
Tablet 500mg
Modified Release Tablet 750mg
(4)
Unit
1 Tablet
1 Tablet
1 Tablet
1 Tablet
1 Tablet
1 Tablet
1 Tablet
1 Tablet
1 Tablet
1 Tablet
1 Tablet
Ceiling Price (Rs.)
12 Levetiracetam
Tablet 750mg
1 Tablet
(5)
1.78
5.02 12.31
2.14
4.16 3.17 4.94 8.55 5.57
11.40
16.32 16.98 Sl. Name of the No. Scheduled

Formulation
13 Lorazepam
14 Lorazepam
15 Sodium Valproate
16 Mebendazole
Diethylcarbamazine
17 (DEC)
18 Cefadroxil Artemether (A)
19 +Lumefantrine(B) Artemether (A)
20 +Lumefantrine(B)
21 Cefixime
22 Clarithromycin
23 Clarithromycin
24 Cycloserine
25 Ethionamide
26 Levofloxacin
27 Levofloxacin
28 Levofloxacin
29 Linezolid
30 Moxifloxacin
31 Rifampicin
32 Fluconazole
33 Abacavir
Abacavir (A)
34 +Lamivudine(B)
35 Nevirapine
36 Raltegravir
37 Darunavir
38 Entecavir
39 Sofosbuvir
40 Clindamycin
41 Clindamycin
42 Flunarizine
43 Flunarizine
Levodopa (A)
44 +Carbidopa(B)
Levodopa (A)
45 +Carbidopa(B)
46 Levodopa (A)
Dosage form and strength
Unit
1 Tablet 1 Tablet 1 Tablet 1 Tablet
1 Tablet 1 Tablet
1 Tablet
1 Tablet
1 Tablet
1 Tablet
1 Tablet
1 Capsule 1 Tablet
1 Tablet
1 Tablet
1 Tablet
1 Tablet
1 Tablet
1 Capsule 1 Tablet
1 Tablet
1 Tablet
1 Tablet
1 Tablet
1 Tablet
1 Tablet
1 Tablet
1 Capsule 1 Capsule 1 Tablet
1 Tablet 1 Tablet
1 Tablet 1 Tablet
Ceiling Price (Rs.)
2.06 2.51 3.98 2.59
1.49 3.99
22.75
11.28 19.71 21.04 34.61 52.79 13.21
4.25
7.85 10.69 31.81 22.79 10.13 26.53 43.34
64.50
14.09 131.81 137.73 116.15 468.32
14.59 25.30 2.21 4.30
2.30
1.57 3.94
Tablet Tablet Tablet Tablet
1mg 2mg 300mg 100 mg
100mg 500mg
Tablet
Tablet
Tablet 80mg(A)+480mg(B) Tablet 20 mg (A) + 120 mg (B)
Tablet 400mg
Tablet 250mg
Tablet 500mg Capsule250mg
Tablet 250mg
Tablet 250mg
Tablet 500mg
Tablet 750mg
Tablet 600mg
Tablet 400mg
Capsule 600mg
Tablet 400mg
Tablet 300 mg
Tablet 600mg (A) +300mg (B)
Tablet 200 mg
Tablet 400mg
Tablet 600mg
Tablet 1mg
Tablet 400mg
Capsule 150mg Capsule 300mg
Tablet 5mg
Tablet 10mg
Tablet 100 mg (A) + 25 mg (B)
Tablet 100 mg (A) + 10 mg (B)
Tablet 250mg(A) Sl. Name of the No. Scheduled

Formulation
+Carbidopa(B)
47 Isosorbide dinitrate
48 Amlodipine
49 Amlodipine
50 Amlodipine
51 Ramipril
52 Ramipril
53 Telmisartan
54 Telmisartan
55 Telmisartan
56 Metformin
57 Metformin
58 Glimepiride
59 Glimepiride
60 Donepezil
61 Donepezil
62 Atorvastatin
63 Atorvastatin
64 Atorvastatin
65 Baclofen
66 Baclofen
67 Baclofen
68 Levothyroxine
69 Levothyroxine
70 Levothyroxine
71 Levothyroxine
72 Levothyroxine
73 Levothyroxine
74 Metformin
75 Vecuronium
76 Vecuronium
77 Capecitabine
78 Misoprostol
79 Cholecalciferol
80 Mesna
81 Mefenamic acid
82 Haloperidol
Dosage form and strength
+25mg(B) Tablet 5mg
Tablet 2.5mg
Tablet 5mg
Tablet 10mg
Tablet 2.5 mg
Tablet 5mg
Tablet 20mg
Tablet 40mg
Tablet 80mg
Tablet 1000mg
Tablet 500mg
Tablet 2mg
Tablet 1mg
Tablet 10mg
Tablet 5mg
Tablet 40mg
Tablet 20mg
Tablet 10mg
Tablet 20mg
Tablet 10mg
Tablet 5mg
Tablet 50mcg
Tablet 75mcg
Tablet 88 mcg
Tablet 150 mcg
Tablet 112 mcg
Tablet 25 mcg
Modified release Tablet 1000mg
Powder for injection 10mg
Powder for injection 4 mg Tablet 500mg
Tablet 200mcg
Tablet 1000 IU
Injection 100mg/mL
Oral liquid 100mg/5mL(p) Tablet 1.5mg
Unit
1 Tablet 1 Tablet 1 Tablet 1 Tablet 1 Tablet 1 Tablet 1 Tablet 1 Tablet 1 Tablet 1 Tablet 1 Tablet 1 Tablet 1 Tablet 1 Tablet 1 Tablet 1 Tablet 1 Tablet 1 Tablet 1 Tablet 1 Tablet 1 Tablet 1 Tablet 1 Tablet 1 Tablet 1 Tablet 1 Tablet 1 Tablet
1 Tablet
Each Vial Each Vial 1 Tablet 1 Tablet 1 Tablet 1 ML
1 ML
1 Tablet
Ceiling Price (Rs.)
0.73 1.59 2.23 4.81 4.65 7.30 3.44 6.03 9.24 3.11 1.77 5.11 3.27
15.24 10.57 16.92 11.01
4.38 14.52 10.39
5.68 0.92 1.28 1.47 1.59 1.48 1.29
3.52
104.67 66.36 100.53 16.92 3.84 13.83 0.50 1.37

Sl. No.
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
Name of the Scheduled Formulation
Haloperidol
Haloperidol
Bicalutamide
Letrozole
Mycophenolate mofetil
Amitriptyline
Amitriptyline
Heparin
Heparin
Amitriptyline
Fluoxetine
Fluoxetine
Fluoxetine
Fluoxetine
Tacrolimus
Tacrolimus
Tacrolimus
Temozolomide
Temozolomide
Zolpidem
Zolpidem
Loperamide
Risperidone
Risperidone
Dosage form and strength
Tablet 5mg
Tablet 10mg
Tablet 50mg
Tablet 2.5mg
Tablet 500mg
Tablet 50mg
Tablet 75mg
Injection 1000IU/mL
Injection 5000IU/mL
Tablet 25mg
Capsule 20 mg
Capsule 60 mg
Capsule 40 mg
Capsule 10 mg
Capsule 0.5mg
Capsule 1mg
Capsule 2mg
Capsule 20 mg
Capsule 250mg
Tablet 5mg
Tablet 10mg
Tablet 2mg
Tablet 1 mg
Tablet 2 mg
Unit
1 Tablet
1 Tablet
1 Tablet
1 Tablet
1 Tablet
1 Tablet
1 Tablet
1 ML
1 ML
1 Tablet
1 Capsule
1 Capsule
1 Capsule
1 Capsule
1 Capusle
1 Capusle
1 Capusle
1 Capsule
1 Capsule
1 Tablet
1 Tablet
1 Tablet
1 Tablet
1 Tablet
Ceiling Price (Rs.)
107 Risperidone Note:
3.18
4.26 38.62 26.15 65.89
5.34
4.77 18.92 53.48
2.16 3.56 9.90 5.79 2.96
18.43 36.23 75.22
393.60 3838.48 5.44 7.59 2.03 2.66 4.00 Tablet 4 mg 1 Tablet 6.56
(a) All manufacturers of scheduled formulation, selling the branded or generic or both the versions of scheduled formulations at a price higher than the ceiling price (plus Goods and Services Tax as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any.
(b) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any, shall continue to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013.

(c) The manufacturers may add goods and services tax only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above said table.
(d) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
(e) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
(f) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013.
(g) The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and / or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of discontinuation.
(h) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955.
(i) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.
PN/237/105/2022/F F. No. 8(105)/2022/D.P./NPPA-Div.-II
(Mahaveer Saini) Deputy Director (Pricing)

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: